Evexia Lifecare Ltd Stock Hits 52-Week Low at Rs.1.42

Recent Price Movement and Market Context

On 11 Mar 2026, Evexia Lifecare Ltd’s share price fell by 2.72% during the trading session, closing at Rs.1.42, its lowest level in the past year. This decline comes after two consecutive days of losses, cumulatively eroding 5.88% of the stock’s value. The stock’s performance today notably lagged behind the edible oil sector, underperforming by 2.02%.

The broader market environment has also been challenging. The Sensex opened flat but subsequently dropped sharply by 1,096.51 points, or 1.36%, settling at 77,142.40. This marked the third consecutive weekly decline for the Sensex, which has lost 6.85% over the past three weeks. The index is currently trading below its 50-day moving average, which itself is positioned below the 200-day moving average, signalling a bearish trend. In contrast, some indices such as the NIFTY MIDCAP150 and NIFTY SMALLCAP250 reached new 52-week highs, highlighting a divergence within the market.

Technical Indicators and Moving Averages

Evexia Lifecare’s technical profile remains weak. The stock is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — indicating sustained downward momentum. Weekly and monthly technical indicators present a mixed picture: while the MACD shows mild bullishness on a weekly basis, monthly signals remain bearish. The Bollinger Bands and Dow Theory assessments also reflect bearish trends on a monthly scale. The Relative Strength Index (RSI) does not currently signal any clear momentum, suggesting a lack of directional conviction among traders.

Long-Term Performance and Financial Metrics

Over the past year, Evexia Lifecare Ltd has delivered a total return of -43.70%, significantly underperforming the Sensex, which posted a positive return of 4.09% during the same period. The stock’s 52-week high was Rs.3.04, underscoring the extent of the decline to the current low of Rs.1.42.

Financially, the company’s fundamentals have shown signs of strain. Operating profits have contracted at a compound annual growth rate (CAGR) of -23.63% over the last five years. Profitability metrics remain subdued, with an average Return on Equity (ROE) of just 0.88%, indicating limited earnings generated per unit of shareholder funds. The Return on Capital Employed (ROCE) stands at a marginal 0.1%, reflecting modest efficiency in capital utilisation.

Debt servicing capacity is a concern, with a Debt to EBITDA ratio of -1.00 times, suggesting elevated leverage relative to earnings before interest, taxes, depreciation, and amortisation. Profitability has also deteriorated sharply, with profits falling by 60.3% over the past year.

Despite these challenges, the stock’s valuation metrics suggest it is trading at a discount relative to its peers’ historical averages. The Enterprise Value to Capital Employed ratio is 0.8, indicating a fair valuation in the context of its capital base.

Shareholding and Market Grade

Evexia Lifecare Ltd’s majority shareholders are non-institutional investors. The company’s market capitalisation grade is rated 4, reflecting its size and liquidity profile. The overall Mojo Score assigned to the stock is 20.0, with a Mojo Grade of Strong Sell as of 28 Apr 2025, an upgrade from the previous Sell rating. This grading reflects the company’s weak long-term fundamentals and recent performance trends.

Sector and Market Comparison

Within the edible oil sector, Evexia Lifecare Ltd’s performance contrasts with some peers that have maintained steadier valuations and earnings growth. The sector itself has experienced mixed trends, with certain midcap and smallcap indices reaching new highs even as the broader market and large-cap indices have faced pressure. This divergence highlights the uneven impact of market conditions across different segments.

The stock’s underperformance relative to the BSE500 index over the last three years, one year, and three months further emphasises its subdued market standing. The cumulative effect of declining profitability, leverage concerns, and weak returns on equity has contributed to the stock’s current valuation and price trajectory.

Summary of Technical and Fundamental Outlook

Evexia Lifecare Ltd’s share price decline to Rs.1.42 marks a significant milestone in its recent downtrend, reflecting both market-wide pressures and company-specific financial challenges. The stock’s position below all major moving averages and the bearish signals from multiple technical indicators underscore the prevailing negative momentum. Meanwhile, fundamental metrics such as operating profit contraction, low ROE, and high debt ratios provide context for the stock’s valuation and market sentiment.

While the stock is trading at a discount relative to peers, the combination of weak profitability and subdued growth has weighed on investor confidence. The company’s flat results reported in December 2025 further illustrate the challenges faced in improving near-term financial performance.

Market Environment Impact

The broader market environment has also been unfavourable. The Sensex’s sharp fall and its position below key moving averages signal a cautious market mood. This environment has likely compounded the pressures on stocks like Evexia Lifecare Ltd, which are already contending with internal financial headwinds.

Conclusion

Evexia Lifecare Ltd’s fall to a 52-week low of Rs.1.42 reflects a confluence of factors including sustained declines in profitability, leverage concerns, and a challenging market backdrop. The stock’s technical and fundamental indicators collectively point to a period of subdued performance relative to sector peers and broader indices. This development is consistent with the company’s recent rating as a Strong Sell by MarketsMOJO, underscoring the ongoing difficulties faced by the company in regaining upward momentum.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →